文献速递甲状腺疾病

碘酪氨酸被鉴定为甲状腺激素转运体MCT8的新型底物

Identification of Iodotyrosines as Novel Substrates for the Thyroid Hormone Transporter MCT8.
PubMed 文献 · Thyroid · 2024-05-10

本研究通过爪蟾卵母细胞裂解液的液相色谱-质谱代谢组分析,鉴定MCT8过表达后丰度差异的候选代谢物,并在转染COS-1细胞和人成纤维细胞中验证转运。结果显示二碘酪氨酸(DIT)和一碘酪氨酸(MIT)可被MCT8外排,且与甲状腺激素转运相互干扰,作者提出未来需阐明MCT8在体内是否也转运碘酪氨酸。

要点

  • 代谢组分析鉴定出87种候选代谢物在MCT8注射卵母细胞中丰度差异达2.0倍,包括DIT、谷氨酸和谷氨酰胺。
  • 表达MCT8的COS-1细胞对[125I]-DIT的胞内蓄积降低2.2倍,该效应可被T3(IC50: 2.5 ± 1.5 µM)或T4(IC50: 5.8 ± 1.3 µM)大幅阻断。
  • MCT8表达使COS-1细胞对[125I]-MIT的胞内蓄积降低50%,但未改变[3H]-谷氨酸或[3H]-谷氨酰胺的蓄积。

核心结论

  • 作者认为,碘酪氨酸DIT和MIT可被MCT8外排,且MIT和DIT在体外干扰MCT8介导的甲状腺激素转运,反之亦然。
  • 作者提出,未来研究应阐明在甲状腺滤泡细胞高表达的MCT8在体内是否也转运碘酪氨酸。

研究设计与样本

  • 研究采用对照与MCT8过表达爪蟾卵母细胞裂解液进行液相色谱-质谱代谢组分析,以鉴定候选底物。
  • 候选底物在瞬时转染的COS-1细胞和內源性表达MCT8的人成纤维细胞中通过直接转运研究验证,并测定转运饱和及甲状腺激素转运的顺式抑制强度。

主要发现

  • 代谢组分析鉴定出21个质荷比对应87种候选代谢物,在MCT8注射卵母细胞中较对照丰度差异达2.0倍,包括3,5-二碘酪氨酸(DIT)、谷氨酸和谷氨酰胺。
  • 表达MCT8的COS-1细胞对[125I]-DIT的胞内蓄积较对照细胞低2.2倍,该效应在T3(IC50: 2.5 ± 1.5 µM)或T4(IC50: 5.8 ± 1.3 µM)存在时大幅阻断。
  • 增加DIT浓度可增强T3和T4的蓄积;MCT8特异性抑制剂silychristin增加人成纤维细胞中DIT的胞内蓄积。
  • 表达MCT8的COS-1细胞对[125I]-3-一碘酪氨酸(MIT)的胞内蓄积降低50%,但未改变[3H]-谷氨酸或[3H]-谷氨酰胺的胞内蓄积。
  • 人成纤维细胞研究中,对照成纤维细胞较MCT8缺陷患者来源成纤维细胞的谷氨酸摄取高1.5-1.9倍,且该摄取不受silychristin影响。

关键数值与推荐

  • MCT8过表达卵母细胞中候选代谢物丰度差异阈值为2.0倍(较对照)。
  • T3对MCT8介导DIT蓄积效应的IC50为2.5 ± 1.5 µM,T4为5.8 ± 1.3 µM。
  • 表达MCT8的COS-1细胞对[125I]-DIT胞内蓄积较对照低2.2倍,对[125I]-MIT胞内蓄积降低50%。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 作者提出未来研究应阐明MCT8在体内是否也转运碘酪氨酸。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Monocarboxylate transporter 8 (MCT8) is the most specific thyroid hormone transporter identified to date, deficiency of which has been associated with severe intellectual and motor disability and abnormal serum thyroid function tests. However, it is presently unknown if MCT8, similar to other thyroid hormone transporters, also accepts additional substrates, and if disruption of their transport may contribute to the observed phenotype. Methods: In this study, we aimed to identify such substrates by applying liquid chromatography-mass spectrometry-based metabolome analysis in lysates of control and MCT8-overexpressing Xenopus oocytes. A subset of identified candidate substrates were validated by direct transport studies in transiently transfected COS-1 cells and human fibroblasts, which endogenously express MCT8. Moreover, transport characteristics were determined, including transport saturation and cis-inhibition potency of thyroid hormone transport. Results: Metabolome analysis identified 21 m/z ratios, corresponding to 87 candidate metabolites, with a 2.0-times differential abundance in MCT8-injected oocytes compared with controls. These metabolites included 3,5-diiodotyrosine (DIT) and several amino acids, including glutamate and glutamine. In accordance, MCT8-expressing COS-1 cells had 2.2-times lower intracellular accumulation of [125I]-DIT compared with control cells. This effect was largely blocked in the presence of 3,3',5-triiodothyronine (T3) (IC50: 2.5 ± 1.5 µM) or thyroxine (T4) (IC50: 5.8 ± 1.3 µM). Conversely, increasing concentrations of DIT enhanced the accumulation of T3 and T4. The MCT8-specific inhibitor silychristin increased the intracellular accumulation of DIT in human fibroblasts. COS-1 cells expressing MCT8 also exhibited a 50% reduction in intracellular accumulation of [125I]-3-monoiodotyrosine (MIT). In contrast, COS-1 cells expressing MCT8 did not alter the intracellular accumulation of [3H]-glutamate or [3H]-glutamine. However, studies in human fibroblasts showed a 1.5-1.9 times higher glutamate uptake in control fibroblasts compared with fibroblasts derived from patients with MCT8 deficiency, which was not affected in the presence of silychristin. Conclusions: Taken together, our results suggest that the iodotyrosines DIT and MIT can be exported by MCT8. MIT and DIT interfere with MCT8-mediated transport of thyroid hormone in vitro and vice versa. Future studies should elucidate if MCT8, being highly expressed in thyroidal follicular cells, also transports iodotyrosines in vivo.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Groeneweg S, Zevenbergen C, Lima de Souza EC, et al. Identification of Iodotyrosines as Novel Substrates for the Thyroid Hormone Transporter MCT8. Thyroid. 2024. PMID: 38661522. doi:10.1089/thy.2023.0551

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。